Logo de 22nd International Symposium on Bioluminescence and Chemiluminescence & 20th International Symposium on Luminescence Spectroscopy
Wait a moment for the page to load

Enter your credentials

Fechar janela

Sign up

Forgot your password?

Logo 22nd ISBC & 20th ISLS


Analytical, clinical and medical applications of luminescence

Lanmodulin as a Novel Reagent for Lanthanide-Based Diagnostics

Leonidas G. Bachas1, Gili Lokiec1, Miguel Colina2, Emre Dikici3, Sapna Deo2, Sylvia Daunert2

1Department of Chemistry, University of Miami, Miami, FL, 33146, USA, 2Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA, 32Department of Biochemistry and Molecular Biology, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA

E-mail: bachas@miami.edu

Lanthanides have unique luminescence properties with sharp emission bands and long luminescence lifetimes. Lanmodulin, (LanM) is a newly discovered protein that binds to lanthanides in the picomolar range, making it ideal as a reagent in the development of imaging technologies. To image the cancerous tissues that are well discerned from the rest of the body, the contrast agent must preferentially concentrate in the cancerous tissue. This can be achieved using tumor specific targeting moieties. We have used lanmodulin along with a tumor-specific targeting moiety as a tool for cancer imaging. Specifically, we have designed a diagnostic test for HER2+ breast cancer by employing a human epidermal group factor receptor 2 (HER2)-specific antibody mimetic fused to lanmodulin as the imaging reagent that targets and binds the HER2 receptors, which are overexpressed in HER2+ breast cancer. For this purpose, we prepared a novel fusion protein, DARPin/LanM, by genetically fusing the gene for the HER2-specific designed ankyrin repeat protein (DARPin) to the gene for lanmodulin. HER2 negative and positive breast cancer cell lines were studied to assess the targeting ability of the DARPin/LanM reagent and its toxicity. We envision that our newly developed reagent has the potential to be translated into a series of nanomedicine diagnostic tools and find applications both in in vitro diagnostics and in vivo imaging technologies.

Keywords: Lanmodulin, diagnostics, imaging


Search for submitted abstracts

You can select one or more search filters